| Product Name | Lapatinib-13C2,15N |
| Product Code | DA-L117-c |
| Chemical name | Lapatinib-13C2,15N |
| Synonyms | N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine-13C2,15N; GSK 572016-13C2,15N; GW 572016-13C2,15N; GW 572016X-13C2,15N; |
| Impurity | NA |
| CAS Number | 1246819-07-7 |
| Alternate CAS # | NA |
| Molecular form | C2713C2H26ClFN315NO4S |
| Appearance | Pale Yellow Solid |
| Melting Point | NA |
| Mol. Weight | 584.04 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | stable isotopes,pharmaceutical standards,intermediates,fine chemicals,tyrosine kinase inhibitors |
| Boiling Point | NA |
| Applications | Labelled Lapatinib. Reversible dual inhibitor of ErbB1 and ErbB2 tyrosine kinases. Antineoplastic. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
